Rench Wealth Management Inc. Trims Stake in Lam Research Corporation $LRCX

Key Points

• Rench Wealth Management cut its Lam Research stake by 15.8% in the second quarter, selling 11,284 shares and retaining 60,262 shares valued at approximately $26.1 million. Lam Research remains the firm’s second-largest holding and represents 7.1% of its portfolio.
• Lam Research reported strong quarterly results, with EPS of $1.82 and revenue of $6.72 billion, exceeding analyst estimates; revenue grew 30% year over year. The company also raised its quarterly dividend to $0.33 per share.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and an average price target of $361.81, although the stock’s elevated valuation and substantial recent gains could increase its exposure to profit-taking.

Rench Wealth Management Inc. trimmed its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 15.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 60,262 shares of the semiconductor company's stock after selling 11,284 shares during the period. Lam Research comprises 7.1% of Rench Wealth Management Inc.'s investment portfolio, making the stock its 2nd largest position. Rench Wealth Management Inc.'s holdings in Lam Research were worth $26,113,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. California State Teachers Retirement System grew its position in Lam Research by 42,619.5% during the second quarter. California State Teachers Retirement System now owns 821,470,614 shares of the semiconductor company's stock valued at $355,967,861,000 after acquiring an additional 819,547,672 shares during the last quarter. Norges Bank bought a new stake in shares of Lam Research in the 4th quarter worth approximately $3,645,427,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock worth $2,344,347,000 after acquiring an additional 10,666,540 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of Lam Research by 411.8% in the 2nd quarter. Van ECK Associates Corp now owns 11,089,395 shares of the semiconductor company's stock valued at $4,805,368,000 after purchasing an additional 8,922,854 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Lam Research in the 2nd quarter valued at $3,777,585,000. Institutional investors own 84.61% of the company's stock.

Lam Research Stock Performance

NASDAQ:LRCX opened at $315.84 on Thursday. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The firm's fifty day simple moving average is $315.51 and its 200 day simple moving average is $293.41. The stock has a market cap of $395.22 billion, a P/E ratio of 54.83, a price-to-earnings-growth ratio of 1.27 and a beta of 1.85. Lam Research Corporation has a twelve month low of $104.61 and a twelve month high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. During the same period in the prior year, the business earned $1.33 EPS. The company's revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, research analysts predict that Lam Research Corporation will post 9.33 EPS for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be given a dividend of $0.33 per share. This is an increase from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Wednesday, September 23rd. Lam Research's dividend payout ratio is presently 18.06%.

Insider Transactions at Lam Research

In other Lam Research news, insider Ava Harter sold 5,000 shares of Lam Research stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the sale, the insider directly owned 42,462 shares of the company's stock, valued at approximately $12,843,056.52. The trade was a 10.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the company's stock in a transaction that occurred on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the transaction, the director owned 87,142 shares in the company, valued at $29,192,570. This trade represents a 17.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.31% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

LRCX has been the topic of a number of analyst reports. TD Cowen reiterated a "buy" rating and issued a $400.00 target price (up from $340.00) on shares of Lam Research in a research report on Thursday, July 9th. Needham & Company LLC reiterated a "buy" rating and issued a $390.00 price objective on shares of Lam Research in a report on Thursday, July 30th. Bank of America increased their target price on Lam Research from $330.00 to $480.00 and gave the company a "buy" rating in a report on Tuesday, June 23rd. Raymond James Financial set a $425.00 price target on Lam Research in a research report on Wednesday, June 10th. Finally, Susquehanna reaffirmed a "positive" rating and issued a $475.00 price target (up from $385.00) on shares of Lam Research in a research note on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $361.81.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Analyst sentiment remains favorable, with Wall Street maintaining a consensus “Moderate Buy” view. Recent coverage also highlights Lam Research’s exposure to artificial intelligence, high-bandwidth memory and advanced DRAM investment, which could support demand for its semiconductor-manufacturing equipment. Consensus rating article Lam Research momentum article
• Positive Sentiment: Lam’s latest quarterly results exceeded expectations, with earnings per share of $1.82 versus the $1.69 consensus and revenue of $6.72 billion versus $6.66 billion. Revenue increased 30% year over year, and management’s next-quarter earnings guidance points to continued growth. These results underpin the long-term bullish case. Three reasons investors favor Lam Research
• Neutral Sentiment: Lam Research presented at Citi’s 2026 Global TMT Conference. The event could provide additional commentary on customer spending, AI-related demand and industry trends, but the supplied report does not identify a material new forecast or announcement. Citi conference transcript
• Negative Sentiment: The stock’s recent rise—nearly tripling over the past year and gaining about 45% in six months—has left investors vulnerable to profit-taking. With a high earnings multiple, even a normal market pullback or weaker risk appetite can pressure LRCX despite strong operating results. Lam Research larger market drop
• Negative Sentiment: Several articles describe clinical studies involving imaging, MRI or compression therapy. These items appear to be incorrectly associated with Lam Research and do not represent developments in the semiconductor-equipment company; investors should disregard them when assessing LRCX.

Lam Research Profile

Lam Research Corporation is a semiconductor equipment company that develops and manufactures systems used in the fabrication of integrated circuits. Its equipment supports key wafer-processing steps, including deposition, etch, wafer cleaning, and related processes used to create and connect the microscopic features found on semiconductor devices.

The company serves semiconductor manufacturers producing a range of products, including memory, logic, and specialty chips. In addition to manufacturing equipment, Lam Research provides installation, maintenance, spare parts, upgrades, technical support, and other services intended to help customers operate and improve their fabrication facilities.

Founded in 1980, Lam Research is headquartered in Fremont, California, and serves customers through a global network of offices, engineering facilities, and support operations.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.